R N Brogden, T M Speight, G S Avery. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAdultAminobutyrates/analogs & derivativesAnimalsChlorobenzenes/pharmacologyChlorobenzenes/therapeutic useChronic DiseaseClinical Trials as TopicDecerebrate StateDiazepam/pharmacologyDrug EvaluationElectroencephalographyHumansIntestinal AbsorptionMiddle AgedMotor Neurons/drug effectsMultiple Sclerosis/drug therapyMuscular Diseases/drug therapyPlacebosReflex, Monosynaptic/drug effectsReflex, Stretch/drug effectsRheumatic Diseases/drug therapySpinal Diseases/drug therapySynaptic Transmission/drug effectsTime Factorsgamma-Aminobutyric Acid/adverse effectsgamma-Aminobutyric Acid/analogs & derivativesgamma-Aminobutyric Acid/metabolismgamma-Aminobutyric Acid/pharmacologygamma-Aminobutyric Acid/poisoninggamma-Aminobutyric Acid/therapeutic use
Substances: See more » AminobutyratesChlorobenzenesPlacebosgamma-Aminobutyric AcidDiazepam
Year: 1974 PMID: 4154834 DOI: 10.2165/00003495-197408010-00001
Source DB: PubMed Journal: Drugs ISSN: 0012-6667 Impact factor: 9.546